Kwality Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 90.26 | 80.36 | 92.56 |
| Operating Expense | 70.35 | 62.72 | 78.22 |
| Net Profit | 8.49 | 8.37 | 4.50 |
| Net Profit Margin | 9.41 | 10.42 | 4.86 |
| Earning Per Share | 8.18 | 8.06 | 4.33 |
| EBIDTA | 19.88 | 17.67 | 14.17 |
| Effective Tax Rate | 20.45 | 15.88 | 10.95 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 90.26 |
| Operating Expense | 70.35 |
| Net Profit | 8.49 |
| Net Profit Margin | 9.41 |
| Earning Per Share | 8.18 |
| EBIDTA | 19.88 |
| Effective Tax Rate | 20.45 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 307.17 | 250.99 | 456.13 |
| Operating Expenses Annual | 240.54 | 190.71 | 284.41 |
| Operating Profit Annual | 61.36 | 46.70 | 175.24 |
| Interest Annual | 10.39 | 6.02 | 2.92 |
| Depreciation | 19.51 | 14.92 | 10.64 |
| Net Profit Annual | 23.98 | 19.47 | 120.05 |
| Tax Annual | 7.48 | 6.29 | 41.63 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 307.17 |
| Operating Expenses Annual | 240.54 |
| Operating Profit Annual | 61.36 |
| Interest Annual | 10.39 |
| Depreciation | 19.51 |
| Net Profit Annual | 23.98 |
| Tax Annual | 7.48 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.80 | 7.06 | 5.13 |
| Cash Flow from Operations | 43.35 | 42.19 | 59.24 |
| Cash Flow from Investing | -26.40 | -48.44 | -62.98 |
| Cash Flow from Financing | -17.40 | 0.99 | 5.66 |
| Cash Flow at the End | 1.35 | 1.80 | 7.06 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1.80 |
| Cash Flow from Operations | 43.35 |
| Cash Flow from Investing | -26.40 |
| Cash Flow from Financing | -17.40 |
| Cash Flow at the End | 1.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 22.29 | 25.41 | 38.42 |
| PBIT Margin (%) | 15.94 | 19.46 | 36.09 |
| PBT Margin (%) | 14.41 | 16.52 | 23.73 |
| Net PROFIT Margin (%) | 7.81 | 7.76 | 26.32 |
| Return On Networth / Equity (%) | 13.74 | 16.56 | 98.62 |
| Return On Networth /Employed (%) | 15.90 | 18.47 | 94.24 |
| Return On Assets (%) | 7.73 | 7.37 | 68.43 |
| Total Debt / Equity (X) | 0.44 | 0.38 | 0.39 |
| Asset Turnover Ratio (%) | 0.99 | 0.95 | 2.60 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 22.29 |
| PBIT Margin (%) | 15.94 |
| PBT Margin (%) | 14.41 |
| Net PROFIT Margin (%) | 7.81 |
| Return On Networth / Equity (%) | 13.74 |
| Return On Networth /Employed (%) | 15.90 |
| Return On Assets (%) | 7.73 |
| Total Debt / Equity (X) | 0.44 |
| Asset Turnover Ratio (%) | 0.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 138.18 | 119.57 | 90.77 |
| Total Current Assets Annual | 243.38 | 207.52 | 227.32 |
| Non Current Assets Annual | 154.19 | 149.06 | 115.36 |
| Total Shareholders Funds Annual | 225.95 | 202.03 | 182.56 |
| Total Assets Annual | 397.57 | 356.58 | 342.68 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 138.18 |
| Total Current Assets Annual | 243.38 |
| Non Current Assets Annual | 154.19 |
| Total Shareholders Funds Annual | 225.95 |
| Total Assets Annual | 397.57 |
EPS (INR)
Expected
8.16
Reported
8.15
Surprise
-0.12%
Jun 2024
EPS beaten by -0.12%
Mar 2024
EPS beaten by -0.12%
Dec 2023
EPS beaten by -2.86%
